Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Press Releases

Press Releases Home
          Inspections, Compliance, Enforcement, and Criminal Investigations
          Criminal Investigations
          Press Releases
          May 31, 2018: Notification of Stolen Fertility Drugs: Gonal-f® RFF Redi-ject® and Gonal-f® Multi-DosePress Releases May 31, 2018: Notification of Stolen Fertility Drugs: Gonal-f® RFF Redi-ject® and Gonal-f® Multi-Dose
  
  	
    Share
    Post
    Linkedin

    Email
    PrintEMD Serono, Inc. of Rockland, Massachusetts is working with the U.S. Food and Drug Administration (FDA), Office of Criminal Investigations (OCI), the Italian Medicines Agency (AIFA), and other law enforcement officials to recover cases of select lots of prescription Gonal-f® RFF Redi-ject® (follitropin alfa injection) and Gonal-f® Multi-Dose (follitropin alfa injection), which are injectable fertility medications that are stored refrigerated and room temperature, respectively. On May 17, 2018, a delivery truck containing the products was hijacked near Bari, Italy, while en route for shipment to the United States. This product’s trademark has been registered with U.S. Customs, who have been alerted to the possibility of illicit shipments into the U.S.

The stolen truck contained 16,457 packages of Gonal-f® RFF Redi-ject® and Gonal-f® Multi-Dose. All of the lot numbers associated with the product stolen are exclusive to this specific shipment. Lot numbers of the stolen products are listed in Table 1 below. The lot numbers can be found on the flap of each box, below the tamper-proof seal and next to the 2D barcode.

Table 1
NAME
			**NDC**
			**LOT**
			**EXPIRATION**
			**DOSAGE FORM**Gonal-f® RFF Redi-ject® 450 IU (0.75 mL)
			44087-1116-1
			BA049137
			5/31/2019
			Liquid for injectionGonal-f® Multi-Dose 1050 IU
			44087-9070-1
			BA049037
			9/30/2019
			Vial powder with diluent for injectionGonal-f® Multi-Dose 450 IU
			44087-9030-1
			BA049143
			2/29/2020
			Vial powder with diluent for injectionGonal-f® Multi-Dose 450 IU
			44087-9030-1
			BA049040
			9/30/2019
			Vial powder with diluent for injection

These lot numbers are not valid for the United States and therefore should be deemed suspect product.

Anyone who may be in possession of these lots should NOT use them and should report the suspect product to EMD Serono by calling 1-888-398-4567 or email us at us.customerservice@emdserono.com.  Anyone who has information regarding this incident, or has received suspicious or unsolicited offers for Gonal-f® RFF Redi-ject® and Gonal-f® Multi-Dose after the date of the theft, should contact the U.S. Food and Drug Administration (FDA) Office of Criminal Investigations at 1-800-551-3989 or to visit the OCI Web Site.

EMD Serono recommends that consumers always inspect the product and label for signs of tampering or contamination prior to use. Gonal-f® RFF Redi-ject® and Gonal-f® Multi-Dose are packaged in "tamper-evident" cartons, meaning that if the package has been opened, it will be evident to the consumer. Consumers can also use EMD Serono’s Check My MedsTM app to scan the 2D barcode on the packaging to verify the authenticity of the serial number on the medication. Consumers, pharmacists and other healthcare professionals should report any evidence of suspected product tampering to EMD Serono by calling 1-888-398-4567 or email us at us.customerservice@emdserono.com. This information should also be reported to FDA's MedWatch Safety Information and Adverse Event Reporting Program.

EMD Serono advises customers and consumers to always purchase product only from licensed distributors and pharmacies to ensure that the product has not deviated from the authorized supply chain (which excludes online pharmacies). For consumer inquiries about a specific product, please call EMD Serono at 1-888-398-4567 or email us at us.customerservice@emdserono.com.

Pharmacies, other healthcare professionals and patients who may be in possession of these lots should NOT use them. If these lots are accidentally used, healthcare professionals and patients are encouraged to report such use, and any adverse events, side effects, or product quality problems related to such use to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Complete and submit the report online
	Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178All Gonal-f® RFF Redi-ject® and Gonal-f® Multi-Dose products with lot numbers other than those listed in the table above meet the standards of quality for distribution and use by patients.

EMD Serono has taken quick and appropriate actions to ensure the safety of its products and will continue to work closely with law enforcement, the FDA, the AIFA, and distribution partners to maintain the integrity of the supply chain.

                                                                                  Content current as of:
      05/31/2018Press Releases
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop